This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Keyword Search

Keyword Search Criteria: Interim Analysis returned 10 record(s)
Monday, 08/02/2010
Interim Analysis: Does It Really Save Time?
Jin-Yi Chen, Merck Research Laboratories


Conditional Power and Predictive Power Approaches to Interim Monitoring in Equivalence Trials
Xiaojiang Zhan, Merck & Co., Inc.
9:20 AM

Optimal Two-Stage Phase II Design Utilizing Partial Information for Long-Term Endpoints
Bo Huang, Pfizer Inc.; Enayet Talukder, Pfizer Inc.; Neal Thomas, Pfizer Inc.
9:35 AM

Should the Conditional Type I Error Be Controlled?
Tie-Hua Ng, FDA
9:50 AM

Achieving the Benefits of Both an Internal Pilot and Interim Analysis in Small Samples
John A. Kairalla, University of Florida; Keith E. Muller, University of Florida; Christopher S. Coffey, The University of Iowa
10:35 AM

Adaptive Sample Size Re-estimation When Interim Results Are Promising
Cyrus R. Mehta, Cytel Inc.
2:25 PM

An Adaptive Noninferiority Study
Pilar Lim, Johnson & Johnson; Qing Liu, Johnson & Johnson; Rosanne Lane, Johnson & Johnson; Barry Schwab, Johnson & Johnson; Allan Sampson, University of Pittsburgh
2:45 PM

Tuesday, 08/03/2010
Disparity-Aided Robust and Efficient Inference for Adaptive Designs with Covariates
Anand Vidyashankar, George Mason University
8:35 AM

Improving the Interim Analysis Process in Adaptive Design Trials
Xiaoyin Fan, Merck & Co., Inc.; Mary Varughese, Merck & Co., Inc.
2:50 PM

Wednesday, 08/04/2010
Case Study: Benefits of an Adaptive Clinical Trial Design in Oncology
Darcy Hille, Merck & Co., Inc.; Christine K. Gause, Merck Research Laboratories; Jason B. Clark, Merck Research Laboratories; Sarah Hoagey, Merck & Co., Inc.; Keaven M. Anderson, Merck Research Laboratories
2:50 PM




2010 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.